Compounded Injections FDA Registered 503B Outsourcing Facility
Legere Pharmaceuticals partners with 503B outsourcing facilities to provide you with the highest quality compounded solutions for IM and IV administration.
Outsourcing facilities are sometimes referred to as 503B facilities because 503B refers to the filling of “office use” or “office administered” medications. The FDA created this new designation of compounding pharmacy to establish a new level of patient care and safety. Outsourcing facilities must comply with strict cGMP (current good manufacturing practices) guidelines, which is the same standards that pharmaceutical manufacturers follow. The outsourcing facilities are now the ONLY pharmacies permitted, under the new law, to provide compounded medications for use in physicians’ offices, clinics, and hospitals.